Search

Your search keyword '"Karadeniz, H."' showing total 323 results

Search Constraints

Start Over You searched for: Author "Karadeniz, H." Remove constraint Author: "Karadeniz, H."
323 results on '"Karadeniz, H."'

Search Results

151. HE-LHC: The High-Energy Large Hadron Collider Future Circular Collider Conceptual Design Report Volume 4

152. Traditionelle und komplementäre medizinversorgung, die patienten mit einer covid-19-diagnose angewendet haben traditional and complementary medicines methods used by patients diagnosed with covid-19

153. Women's health nursing in traditional and complementary medicine practices

155. Covid-19 pandemisinin hemşirelerin mesleki imaj algısına etkisi

156. Reduction of large kinetic mechanisms with a new approach to the necessity analysis method

157. Economic and social situatson of villages of Aşk-i Kara,Ürünlü,Bayramşah,Sögüt,Serviran and Sökman in armudili township of Kütahya county of Hüdavendigar state by tax incomes books of 1845

159. Calcineurin inhibitors in unplanned pregnancies with active lupus disease: A retrospective observational study.

160. Frequency of sarcopenia in Turkish women with systemic lupus erythematosus.

161. Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria.

162. Vascular calcification in Takayasu arteritis: relationship with metabolic syndrome, left ventricular mass index, and intima-media thickness.

163. Bleaching versus color change resistant adhesive in the discoloration of bracket-bonded tooth surfaces: an in vitro study.

164. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.

165. Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?

166. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.

167. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.

168. Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study.

169. Bonded lingual retainer adhesives and discoloration : An in vitro study.

170. Effects of interleukin-1 antagonists on de novo and pre-existing damage in patients with familial Mediterranean fever.

173. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.

174. Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD.

175. Lacrimal gland ultrasonography and elastography as a diagnostic and activity tool for primary Sjögren's syndrome.

176. Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry.

177. Traditional and Complementary Medicines Methods Used by Patients Diagnosed with COVID-19.

178. The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients.

179. Determination of the Voice Parameters in Adult Individuals With Rheumatoid Arthritis and the Relation of Voice With Depression and Inflammation.

180. Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography.

181. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis.

182. Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients.

183. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis.

184. Vaccination Refusal Debate on Social Media in Turkey: A Content Analysis of the Comments on Instagram Blogs.

185. Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors.

186. Determining the musculoskeletal problems of academicians who transitioned to distance education during the COVID-19 pandemic.

188. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.

189. Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Patients With Inflammation of Unknown Origin.

190. Decreased exercise capacity, strength, physical activity level and quality of life in adult patients with familial Mediterranean fever

191. Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists.

192. Predictors of persistent inflammation in familial Mediterranean fever and association with damage.

193. Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report.

194. Parotid elastography: a potential alternative to replace labial biopsy in classification of patients with primary Sjögren's syndrome?

195. IgG4-related disease: a contemporary review

196. Knowledge levels and attitudes of adult individuals about cancer and its risk factors.

197. Factors associated with damage in patients with familial Mediterranean fever.

198. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.

200. Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet's disease.

Catalog

Books, media, physical & digital resources